CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Trauma- and Stressor-Related Disorders DSM-5-TR 309.0-309.9 | ICD-10-CM F43.2x

Adjustment Disorder

Clinically significant emotional or behavioral symptoms emerging within three months of an identifiable, non-catastrophic stressor.

Prevalence5-20% outpatient MH visits
OnsetWithin 3 months of stressor
Sex ratio~2:1 female:male in adults
CourseResolves <6 mo after stressor

Clinical picture

  • Depressed mood, worry, tearfulness, and hopelessness appear disproportionate to the stressor within weeks of its onset.
  • Conduct disturbance predominates in adolescents, with truancy, fighting, vandalism, and reckless driving following family disruption.
  • Common precipitants include job loss, divorce, relocation, a new medical diagnosis, financial crisis, and military deployment.
  • Somatic complaints, insomnia, and declining work or academic performance often bring the patient in rather than any mood complaint.
  • Symptoms typically remit within six months once the stressor and its downstream consequences have actually resolved.
  • Suicidal ideation and attempts occur at rates approaching those in major depression despite the subthreshold framing of the diagnosis.

Criteria snapshot

  • Emotional or behavioral symptoms develop within three months of the onset of an identifiable stressor or set of stressors.
  • Distress is out of proportion to stressor severity when cultural context is accounted for, or it produces significant functional impairment.
  • The disturbance does not meet criteria for another mental disorder and is not merely an exacerbation of a preexisting condition.
  • Symptoms do not represent normal bereavement and resolve within six months after the stressor or its consequences have ended.
  • Subtypes specify depressed mood, anxiety, mixed anxiety and depressed mood, disturbance of conduct, mixed disturbance, or unspecified.

Neurobiology

  • Best conceptualized as a stress-response syndrome rather than a discrete neurobiological entity, and the research base remains thin.
  • HPA axis reactivity, autonomic arousal, and inflammatory markers rise transiently and normalize once the stressor resolves.
  • Allostatic load from cumulative prior stressors lowers the threshold at which a new event produces clinically significant symptoms.
  • Genetic and temperamental vulnerability, including high neuroticism and low resilience, shapes who converts stress into disorder.
  • Chronic unresolved stressors sustain cortisol and sympathetic activation, raising longer-term cardiovascular and metabolic risk.
  • Sleep fragmentation induced by acute stress amplifies emotional reactivity and measurably slows the pace of symptom resolution.

Psychology

  • Diathesis-stress and transactional coping models frame symptoms as a failure of appraisal and coping capacity to meet situational demand.
  • Rumination about the stressor and about one's own failure to manage it converts a time-limited reaction into a persistent syndrome.
  • Loss of role, identity, and predictability, rather than the objective event itself, frequently drives the bulk of the distress.
  • Avoidant coping, escalating substance use, and social withdrawal prevent problem solving and sustain the stressor's impact.
  • Attachment security and available social support strongly moderate both the severity and the duration of the stress reaction.

Differential & comorbidity

  • Rule out major depression, generalized anxiety disorder, PTSD, and acute stress disorder first, since this is a residual diagnosis.
  • Prolonged grief disorder now covers persistent intense grief beyond twelve months in adults and should not be coded here.
  • Normal stress responses lack proportionality or impairment, and culture shapes what counts as an expectable reaction to loss.
  • Comorbid substance use frequently emerges as a coping strategy and should be screened for at every follow-up contact.
  • Screen directly for suicide, since risk is substantial, particularly in adolescents and after job loss or relationship breakdown.

Pharmacologic treatment

  • No medication is FDA-approved; psychotherapy and practical problem solving are first-line for nearly every presentation.
  • A short course of a hypnotic or trazodone 25-100 mg at bedtime may be used briefly for stress-related insomnia.
  • Avoid benzodiazepines beyond a few days, since dependence risk outweighs benefit in a largely self-limited condition.
  • Consider an SSRI when symptoms persist past three months, worsen, or cross the threshold into a full depressive episode.
  • Reassess the diagnosis before committing to long-term medication, because persistence usually signals a different disorder.

Psychotherapy

  • Brief problem-solving therapy and supportive counseling across 4-8 sessions are the best-supported interventions available.
  • CBT targeting appraisal, avoidance, and behavioral activation reduces symptoms and speeds functional return to work or school.
  • Stressor-specific work matters most: grief processing, occupational counseling, or structured adjustment to a medical diagnosis.
  • Group and internet-delivered brief interventions show benefit in occupational, military, and disaster-exposed populations.
  • Crisis intervention paired with concrete environmental change often outperforms purely symptom-focused therapy.

Adjunct options

  • Track with the PHQ-9, GAD-7, and a functional measure every 2-4 weeks to detect conversion to major depression.
  • Mobilize practical resources including employee assistance programs, legal aid, financial counseling, and housing support.
  • Sleep regulation, regular aerobic exercise, and reduced alcohol use accelerate recovery and lower conversion risk.
  • Family and couples sessions address the interpersonal stressor directly rather than treating only the identified patient.
  • Time-limited work modification or medical leave can resolve symptoms faster and more durably than any prescription.

Clinical pearls

  • It is a residual diagnosis: rule out MDD, GAD, and PTSD before settling on it.
  • Subthreshold does not mean low risk; suicide rates rival major depression.
  • If symptoms outlast the stressor by six months, the diagnosis is wrong.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • O'Donnell, M. L., Agathos, J. A., Metcalf, O., Gibson, K., & Lau, W. (2019). Adjustment disorder: Current developments and future directions. International Journal of Environmental Research and Public Health, 16(14), 2537.
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.
  • Strain, J. J., & Diefenbacher, A. (2008). The adjustment disorders: The conundrums of the diagnoses. Comprehensive Psychiatry, 49(2), 121-130.
  • World Health Organization. (2019). International statistical classification of diseases and related health problems (11th ed.). https://icd.who.int/